{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T21:04:53Z","timestamp":1784840693056,"version":"3.55.0"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,7,23]]},"DOI":"10.7759\/cureus.113249","type":"journal-article","created":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T20:52:04Z","timestamp":1784839924000},"source":"Crossref","is-referenced-by-count":0,"title":["Rare Ovarian Sex Cord-Stromal Tumor: Diagnostic Pitfalls and Clinical Management"],"prefix":"10.7759","author":[{"given":"Beatriz","family":"Sousa Ferreira","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Cl\u00e1udia","family":"Rodrigues","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Castelo-Branco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teresa","family":"Carvalho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rita","family":"Sousa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000012865","article-title":"Sertoli-Leydig cell tumors of ovary: a case series","volume":"97","author":"Xu Q","year":"2018","unstructured":"Xu Q, Zou Y, Zhang XF. Sertoli-Leydig cell tumors of ovary: a case series. Medicine (Baltimore). 2018, 97:e12865. 10.1097\/MD.0000000000012865","journal-title":"Medicine (Baltimore)"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1186\/s13048-021-00909-7","article-title":"Characteristics and outcomes analysis of ovarian Sertoli-Leydig cell tumors (SLCTs): analysis of 15 patients","volume":"14","author":"Wang G","year":"2021","unstructured":"Wang G, Zhang R, Li C, Chen A. Characteristics and outcomes analysis of ovarian Sertoli-Leydig cell tumors (SLCTs): analysis of 15 patients. J Ovarian Res. 2021, 14:150. 10.1186\/s13048-021-00909-7","journal-title":"J Ovarian Res"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1007\/s00428-024-03984-5","article-title":"A molecular and immunohistochemical study of 37 cases of ovarian Sertoli-Leydig cell tumor","volume":"487","author":"N\u011bmejcov\u00e1 K","year":"2025","unstructured":"N\u011bmejcov\u00e1 K, H\u00e1jkov\u00e1 N, Krkavcov\u00e1 E, et al.. A molecular and immunohistochemical study of 37 cases of ovarian Sertoli-Leydig cell tumor. Virchows Arch. 2025, 487:127-40. 10.1007\/s00428-024-03984-5","journal-title":"Virchows Arch"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2024.04.005","article-title":"Outcomes in ovarian Sertoli-Leydig cell tumor: a report from the International Pleuropulmonary Blastoma\/DICER1 and Ovarian and Testicular Stromal Tumor registries","volume":"186","author":"Nelson AT","year":"2024","unstructured":"Nelson AT, Harris AK, Watson D, et al.. Outcomes in ovarian Sertoli-Leydig cell tumor: a report from the International Pleuropulmonary Blastoma\/DICER1 and Ovarian and Testicular Stromal Tumor registries. Gynecol Oncol. 2024, 186:117-25. 10.1016\/j.ygyno.2024.04.005","journal-title":"Gynecol Oncol"},{"key":"ref5","unstructured":"Female Genital Tumours. WHO Classification of Tumours, 5th Edition, Volume 4. (2020). Accessed. May 17, 2026: https:\/\/publications.iarc.who.int\/Book-And-Report-Series\/Who-Classification-Of-Tumours\/Female-Genital-Tumours-2020."},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1177\/1179066017695239","article-title":"A case report: ovarian Sertoli-Leydig cell tumor with hyperestrogenism and endometrial hyperplasia in a postmenopausal woman","volume":"8","author":"Tsuzuki Y","year":"2017","unstructured":"Tsuzuki Y, Kikuchi I, Nojima M, Yoshida K, Hashizume A, Tomita S. A case report: ovarian Sertoli-Leydig cell tumor with hyperestrogenism and endometrial hyperplasia in a postmenopausal woman. Jpn Clin Med. 2017, 8:1179066017695239. 10.1177\/1179066017695239","journal-title":"Jpn Clin Med"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1210\/jcemcr\/luae013","article-title":"Sertoli-Leydig cell tumor as a cause of elevated 17-OH progesterone","volume":"2","author":"Chong YY","year":"2024","unstructured":"Chong YY, Wong JL, Ang XH, Lim YL. Sertoli-Leydig cell tumor as a cause of elevated 17-OH progesterone. JCEM Case Rep. 2024, 2:luae013. 10.1210\/jcemcr\/luae013","journal-title":"JCEM Case Rep"},{"key":"ref8","article-title":"Non-epithelial ovarian cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up","volume":"29","author":"Ray-Coquard I","year":"2018","unstructured":"Ray-Coquard I, Morice P, Lorusso D, et al.. Non-epithelial ovarian cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2018. 2018, 29:iv1-18.","journal-title":"Ann Oncol. 2018"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.rmcr.2016.04.004","article-title":"Death by bleomycin pulmonary toxicity in ovarian dysgerminoma with pathologic complete response to chemotherapy. A case report","volume":"18","author":"Calzas Rodr\u00edguez J","year":"2016","unstructured":"Calzas Rodr\u00edguez J, Carmen Juarez Morales MD, Casero MA. Death by bleomycin pulmonary toxicity in ovarian dysgerminoma with pathologic complete response to chemotherapy. A case report. Respir Med Case Rep. 2016, 18:48-50. 10.1016\/j.rmcr.2016.04.004","journal-title":"Respir Med Case Rep"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.humpath.2016.09.005","article-title":"DICER1 hotspot mutations in ovarian Sertoli-Leydig cell tumors: a potential association with androgenic effects","volume":"59","author":"Kato N","year":"2017","unstructured":"Kato N, Kusumi T, Kamataki A, Tsunoda R, Fukase M, Kurose A. DICER1 hotspot mutations in ovarian Sertoli-Leydig cell tumors: a potential association with androgenic effects. Hum Pathol. 2017, 59:41-7. 10.1016\/j.humpath.2016.09.005","journal-title":"Hum Pathol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1634\/theoncologist.2020-0110","article-title":"Clinical characteristics and mutation analyses of ovarian Sertoli-Leydig cell tumors","volume":"25","author":"Yuan Z","year":"2020","unstructured":"Yuan Z, Huo X, Jiang D, et al.. Clinical characteristics and mutation analyses of ovarian Sertoli-Leydig cell tumors. Oncologist. 2020, 25:e1396-405. 10.1634\/theoncologist.2020-0110","journal-title":"Oncologist"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14122998","article-title":"Response to systemic therapies in ovarian adult granulosa cell tumors: a literature review","volume":"14","author":"Brink GJ","year":"2022","unstructured":"Brink GJ, Groeneweg JW, Hooft L, Zweemer RP, Witteveen PO. Response to systemic therapies in ovarian adult granulosa cell tumors: a literature review. Cancers (Basel). 2022, 14:2998. 10.3390\/cancers14122998","journal-title":"Cancers (Basel)"},{"key":"ref13","article-title":"Toxicity and response criteria of the Eastern Cooperative Oncology Group","volume":"5","author":"Oken MM","year":"1982","unstructured":"Oken MM, Creech RH, Tormey DC, Horton J, Davis TE, McFadden ET, Carbone PP. Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol. 1982, 5:649-55.","journal-title":"Am J Clin Oncol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1111\/j.1447-0756.2012.01928.x","article-title":"Sertoli-Leydig cell tumor of the ovary: analysis of a single institution database","volume":"39","author":"Bhat RA","year":"2013","unstructured":"Bhat RA, Lim YK, Chia YN, Yam KL. Sertoli-Leydig cell tumor of the ovary: analysis of a single institution database. J Obstet Gynaecol Res. 2013, 39:305-10. 10.1111\/j.1447-0756.2012.01928.x","journal-title":"J Obstet Gynaecol Res"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1055\/s-0039-1693056","article-title":"Ovarian Sertoli-Leydig cell tumors: epidemiological, clinical and prognostic factors","volume":"41","author":"Castro BG","year":"2019","unstructured":"Castro BG, Souza CP, Andrade CE, Vieira MA, Andrade DA, Reis RD. Ovarian Sertoli-Leydig cell tumors: epidemiological, clinical and prognostic factors. Rev Bras Ginecol Obstet. 2019, 41:440-8. 10.1055\/s-0039-1693056","journal-title":"Rev Bras Ginecol Obstet"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/500906-rare-ovarian-sex-cord-stromal-tumor-diagnostic-pitfalls-and-clinical-management","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T20:52:06Z","timestamp":1784839926000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/500906-rare-ovarian-sex-cord-stromal-tumor-diagnostic-pitfalls-and-clinical-management"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,23]]},"references-count":15,"URL":"https:\/\/doi.org\/10.7759\/cureus.113249","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7,23]]}}}